Large animal models play a crucial role in drug research and development (R&D), with extensive applications in life sciences, the pharmaceutical industry, and healthcare. While mice are the most commonly used experimental animals, their structural differences from humans limit their effectiveness in modeling certain diseases.
With the advent of precision medicine and a deeper understanding of disease mechanisms, large animal models—such as non-human primates, dogs, rabbits, and miniature pigs—have demonstrated distinct advantages and significant value in critical areas of drug development.
Owing to their closer physiological similarity to humans, these models more accurately simulate human disease characteristics. They are particularly valuable in research on cardiovascular diseases, metabolic disorders, inflammatory immune diseases, and neurological conditions.
To assist clients in selecting the most suitable large animal models, Medicilon has developed an innovative, flexible, and reliable pharmacodynamic research service platform. This platform specializes in models such as non-human primates, dogs, rabbits, and miniature pigs, offering comprehensive and in-depth disease model development and pharmacodynamic research.
Share：
marketing@medicilon.com
